Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2300067887Phase 4Not yet recruiting
Phase 4, open-label trial of esketamine in None (2 arms), sponsored by The Fourth Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoint: Vital signs. Planned start Feb 2023; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2300067887.